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Results of these procedures converged on a reference range for Ca of 8.6-10.2 mg/dL  
(Figure 5)..                   
 
 
 
 
 
 
 
 
 
 
Figure 5. Results of best-fit normality plots as a function of assumed interval widths. A. Upper limit (UL) and lower limit (LL) of 
reference ranges. B. Linear correlation coefficient (r2) of best-fit. C. Percent inclusion of normal distribution within interval for 
best-fit. Vertical dashed lines: boundaries of region of converging analyses (based on r2).  Horizontal dashed lines (A): 
average UL and LL based on converging analyses. 
Varying widths of intervals of results having 
symmetry around this midpoint (a necessary 
condition for a normal distribution) were 
assigned for analysis (Figure 3). 
 
 
 
 
 
 
 
 
 
Figure 3. Examples of intervals of results having symmetric 
percentages of results on either side of the defined midpoint. 
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Isolation of the data subset compatible with a 
normal distribution was a two-stage process: 
The point of maximum slope of the cumulative 
patient results distribution was determined to 
define the mean/median of the embedded 
normal distribution (9.4 mg/dL; Figure 2). 
 
 
 
 
 
 
 
Figure 2. Slope of the continuous cumulative patient results 
distribution vs. Ca. Maximum slope was centered at Ca = 9.4 
mg/dL, which was then defined as the normal distribution 
midpoint/median. 
 
 
 
 
 
 
 
 
 
 
 
 
 
For each of these intervals, an iterative search 
was made to determine the central fraction of a 
normal distribution encompassed by each 
interval, as evidenced by the linearity of a 
normality plot when the correct fraction was 
specified (Figure 4). 
 
 
 
 
 
 
 
 
Figure 4. Example of normality plot. For interval = 30% of results 
centered on the midpoint (i.e., midpoint ± 15% of results), the 
maximum linearity of the normality plot (r2 >0.999) occurred when 
assuming that this interval was inclusive of 51% of a normal 
distribution. Correspondingly, the associated reference range 
was 8.65-10.14 mg/dL. Normality plot: x-axis = Ca result (mg/dL); 
y-axis: z value (-∞ to +∞) based on assumed percentile of results 
within the normal distribution. 
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A change in reagents for calcium (Ca) on the 
Roche Cobas c500 used in our laboratory 
analyzer took place in 2013. The previous 
reference range (8.5-10.5 mg/dL) was replaced 
with that from the manufacturer's study (8.6-10.0 
mg/dL), based on correlation of results between 
the new and old assays. As a matter of quality 
assurance, we undertook a post-assay-change 
reevaluation of the reference range change, using 
a method based on that of Bhattacharya [1]. In 
short, the method relies on the assumption that 
the reference range is a normal distribution, which 
assumption enables this distribution to be isolated 
mathematically from within all-comers patient 
distribution data that are not normally distributed.  
The results were used to update our Ca reference range. Normal distribution analysis of patient data subsets by this method can be a 
powerful tool to evaluate reference ranges, simply because it can include a large number of patients using retrospective data. In 
comparison, identification and testing of "normal" patients in similar numbers would be difficult or impractical. In particular, clinical 
verification of a normal population for Ca would be expensive for any large number of patients, involving combined evaluation of Ca, 
renal function, vitamin D status, and PTH. These results demonstrate that one can have reasonable confidence in an esoteric method 
for extraction of a reference range from an all-comers patient results distribution. The related method of Hoffman [3] is more well-known 
but less stringent, being applied with varying degrees of success in recent literature [4-7]. 
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METHODS AND RESULTS 
INTRODUCTION 
A. B. C. 
B. C. 
Primary data were all patient Ca results retrieved 
for a one-month interval (Figure 1). 
 
 
 
 
 
 
 
 
Figure 1. Primary data: cumulative results distribution for all patient 
Ca results retrieved for a one-month interval (January, 2014; n = 
11,684). Solid line: distribution according to 0.1 mg/dL increments 
of reporting. Dashed line: continuous data distribution interpolated 
from original data. Vertical dashed lines: boundaries of reference 
range (8.5-10.0 mg/dL). For this distribution, low Ca = 24.9%, high 
Ca = 9.2%. 
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A. 
The reference range from Figure 5 data was essentially identical (±0.1 mg/dL) to "textbook" 
reference ranges (e.g., [2]).  A comparison of the patient results distribution to the reference range 
distribution is shown in Figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. A. Comparison of patient results cumulative distribution to reference range cumulative distribution. B. Comparison of patient 
results distribution to reference range distribution. C. Residuals between patient results distribution and normal patient distribution 
(residual = patient distribution - reference range distribution). 
